Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
MicroRNA-1 protects the endothelium in acute lung injury
Asawari Korde, Maria Haslip, Prachi Pednekar, Alamzeb Khan, Maurizio Chioccioli, Sameet Mehta, Francesc Lopez-Giraldez, Santos Bermejo, Mauricio Rojas, Charles Dela Cruz, Michael A. Matthay, Jordan S. Pober, Richard W. Pierce, Shervin S. Takyar
Asawari Korde, Maria Haslip, Prachi Pednekar, Alamzeb Khan, Maurizio Chioccioli, Sameet Mehta, Francesc Lopez-Giraldez, Santos Bermejo, Mauricio Rojas, Charles Dela Cruz, Michael A. Matthay, Jordan S. Pober, Richard W. Pierce, Shervin S. Takyar
View: Text | PDF
Research Article Pulmonology Vascular biology

MicroRNA-1 protects the endothelium in acute lung injury

  • Text
  • PDF
Abstract

Acute lung injury (ALI) and its most severe form, acute respiratory distress syndrome (ARDS), cause severe endothelial dysfunction in the lung, and vascular endothelial growth factor (VEGF) is elevated in ARDS. We found that the levels of a VEGF-regulated microRNA, microRNA-1 (miR-1), were reduced in the lung endothelium after acute injury. Pulmonary endothelial cell–specific (EC-specific) overexpression of miR-1 protected the lung against cell death and barrier dysfunction in both murine and human models and increased the survival of mice after pneumonia-induced ALI. miR-1 had an intrinsic protective effect in pulmonary and other types of ECs; it inhibited apoptosis and necroptosis pathways and decreased capillary leak by protecting adherens and tight junctions. Comparative gene expression analysis and RISC recruitment assays identified miR-1 targets in the context of injury, including phosphodiesterase 5A (PDE5A), angiopoietin-2 (ANGPT2), CNKSR family member 3 (CNKSR3), and TNF-α–induced protein 2 (TNFAIP2). We validated miR-1–mediated regulation of ANGPT2 in both mouse and human ECs and found that in a 119-patient pneumonia cohort, miR-1 correlated inversely with ANGPT2. These findings illustrate a previously unknown role of miR-1 as a cytoprotective orchestrator of endothelial responses to acute injury with prognostic and therapeutic potential.

Authors

Asawari Korde, Maria Haslip, Prachi Pednekar, Alamzeb Khan, Maurizio Chioccioli, Sameet Mehta, Francesc Lopez-Giraldez, Santos Bermejo, Mauricio Rojas, Charles Dela Cruz, Michael A. Matthay, Jordan S. Pober, Richard W. Pierce, Shervin S. Takyar

×

Figure 8

miR-1 targets in the injured endothelium.

Options: View larger image (or click on image) Download as PowerPoint
miR-1 targets in the injured endothelium.
(A) Schematic representation o...
(A) Schematic representation of our strategy for selecting the candidate genes. Circles represent the genes that were selected based on the criteria in each group. (B) Heatmap shows the RISC-recruited genes (circle 3 in A). Arrows show the genes from the list that were known to be involved in ALI or cell death. (C) Validation of RISC recruitment for the selected genes (marked by arrows in B). HUVECs were transduced with V-miR-1 or control (V-ctrl) and their lysates were used in an Ago pull-down assay. Expression levels for the selected genes were measured by qRT-PCR in the Ago-immunoprecipitated fraction and normalized to their expression levels in the whole lysate. The values for V-miR-1–transduced cells /V-ctrl–transduced cells are expressed as relative RISC recruitment (n = 4, from 2 experiments). *P < 0.05. (D–G) HUVECs were transfected with miR-1 or control RNA (Ctrl) and treated with TNF-α (10 ng/mL) or vehicle (PBS) and levels of each mRNA/18S in the lysates were measured and expressed as in Figure 3A. Graphs show the levels for (D) phosphodiesterase 5A (PDE5A), (E) connector enhancer of kinase suppressor of Ras (CNKSR3), (F) angiopoietin-2 (ANGPT2), and (G) TNF-α–induced protein 2 (TNFAIP) (n = 6 per group in each, from 2 experiments). *P < 0.05. Error bars represent the SEM. Data were analyzed by unpaired, 2-tailed t test with Welch’s correction or Mann-Whitney U test based on normality.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts